Amelioration of Early Markers of Diabetic Nephropathy by Linagliptin in Fructose-Streptozotocin-Induced Type 2 Diabetic Rats
Conclusions: This study suggests that linagliptin exerts renoprotection against early features of DN in rats probably by inhibition of high glucose-induced renal tubular and glomerular injury thereby hampering KIM-1 and NGAL as well as vanin-1 associated with renal inflammation, fibrosis and oxidative stress.Nephron
Source: Nephron - Category: Urology & Nephrology Source Type: research
More News: Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Metformin | Study | Urology & Nephrology